Cargando…

The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study

Objective: Soy and cocoa have been suggested to be beneficial for diabetes. The aim of this study was to identify the effects of soy protein, isoflavones, and cocoa on glycemic control parameters. Research design and methods: The study was a parallel, double-blind, placebo-controlled study where pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Konya, Judit, Sathyapalan, Thozhukat, Kilpatrick, Eric S., Atkin, Stephen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521701/
https://www.ncbi.nlm.nih.gov/pubmed/31143160
http://dx.doi.org/10.3389/fendo.2019.00296
_version_ 1783419015800029184
author Konya, Judit
Sathyapalan, Thozhukat
Kilpatrick, Eric S.
Atkin, Stephen L.
author_facet Konya, Judit
Sathyapalan, Thozhukat
Kilpatrick, Eric S.
Atkin, Stephen L.
author_sort Konya, Judit
collection PubMed
description Objective: Soy and cocoa have been suggested to be beneficial for diabetes. The aim of this study was to identify the effects of soy protein, isoflavones, and cocoa on glycemic control parameters. Research design and methods: The study was a parallel, double-blind, placebo-controlled study where patients with diet or metformin controlled type 2 diabetes were randomized to, casein soy protein with or without isoflavones (SPI, SP), and with or without cocoa (SPIC, SPC) arms for an 8 week period. Glycemic control and cardiovascular risk factors were assessed prior to and after the completion of the dietary intervention. Sixty participants completed the study. Results: Soy protein improved HbA1c compared to casein (p < 0.05). The addition of isoflavones improved indices of insulin resistance and LDL [delta QUICKIE (SPI: −0.12 ± 0.04 vs. SP: 0.03 ± 0.06, p = 0.03); delta LDL (−0.27 ± 0.41 vs. 0.22 ± 0.43, p = 0.02); percentage change in HOMA (31.02 ± 54.75 vs. −14.42 ± 27.07, p = 0.02); percentage change in QUICKIE (−3.89 ± 7.07 vs. 6.11 ± 10.54, p = 0.01)]. However, the addition of cocoa provided no benefit with or without isoflavones. Summary: Soy protein had intrinsic activity on glycemic control compared to casein. Isoflavones improved both insulin resistance and LDL, but cocoa did not have added benefit on these indices. Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT01754662.
format Online
Article
Text
id pubmed-6521701
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-65217012019-05-29 The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study Konya, Judit Sathyapalan, Thozhukat Kilpatrick, Eric S. Atkin, Stephen L. Front Endocrinol (Lausanne) Endocrinology Objective: Soy and cocoa have been suggested to be beneficial for diabetes. The aim of this study was to identify the effects of soy protein, isoflavones, and cocoa on glycemic control parameters. Research design and methods: The study was a parallel, double-blind, placebo-controlled study where patients with diet or metformin controlled type 2 diabetes were randomized to, casein soy protein with or without isoflavones (SPI, SP), and with or without cocoa (SPIC, SPC) arms for an 8 week period. Glycemic control and cardiovascular risk factors were assessed prior to and after the completion of the dietary intervention. Sixty participants completed the study. Results: Soy protein improved HbA1c compared to casein (p < 0.05). The addition of isoflavones improved indices of insulin resistance and LDL [delta QUICKIE (SPI: −0.12 ± 0.04 vs. SP: 0.03 ± 0.06, p = 0.03); delta LDL (−0.27 ± 0.41 vs. 0.22 ± 0.43, p = 0.02); percentage change in HOMA (31.02 ± 54.75 vs. −14.42 ± 27.07, p = 0.02); percentage change in QUICKIE (−3.89 ± 7.07 vs. 6.11 ± 10.54, p = 0.01)]. However, the addition of cocoa provided no benefit with or without isoflavones. Summary: Soy protein had intrinsic activity on glycemic control compared to casein. Isoflavones improved both insulin resistance and LDL, but cocoa did not have added benefit on these indices. Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT01754662. Frontiers Media S.A. 2019-05-09 /pmc/articles/PMC6521701/ /pubmed/31143160 http://dx.doi.org/10.3389/fendo.2019.00296 Text en Copyright © 2019 Konya, Sathyapalan, Kilpatrick and Atkin. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Konya, Judit
Sathyapalan, Thozhukat
Kilpatrick, Eric S.
Atkin, Stephen L.
The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study
title The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study
title_full The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study
title_fullStr The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study
title_full_unstemmed The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study
title_short The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study
title_sort effects of soy protein and cocoa with or without isoflavones on glycemic control in type 2 diabetes. a double-blind, randomized, placebo-controlled study
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521701/
https://www.ncbi.nlm.nih.gov/pubmed/31143160
http://dx.doi.org/10.3389/fendo.2019.00296
work_keys_str_mv AT konyajudit theeffectsofsoyproteinandcocoawithorwithoutisoflavonesonglycemiccontrolintype2diabetesadoubleblindrandomizedplacebocontrolledstudy
AT sathyapalanthozhukat theeffectsofsoyproteinandcocoawithorwithoutisoflavonesonglycemiccontrolintype2diabetesadoubleblindrandomizedplacebocontrolledstudy
AT kilpatrickerics theeffectsofsoyproteinandcocoawithorwithoutisoflavonesonglycemiccontrolintype2diabetesadoubleblindrandomizedplacebocontrolledstudy
AT atkinstephenl theeffectsofsoyproteinandcocoawithorwithoutisoflavonesonglycemiccontrolintype2diabetesadoubleblindrandomizedplacebocontrolledstudy
AT konyajudit effectsofsoyproteinandcocoawithorwithoutisoflavonesonglycemiccontrolintype2diabetesadoubleblindrandomizedplacebocontrolledstudy
AT sathyapalanthozhukat effectsofsoyproteinandcocoawithorwithoutisoflavonesonglycemiccontrolintype2diabetesadoubleblindrandomizedplacebocontrolledstudy
AT kilpatrickerics effectsofsoyproteinandcocoawithorwithoutisoflavonesonglycemiccontrolintype2diabetesadoubleblindrandomizedplacebocontrolledstudy
AT atkinstephenl effectsofsoyproteinandcocoawithorwithoutisoflavonesonglycemiccontrolintype2diabetesadoubleblindrandomizedplacebocontrolledstudy